Apolipoprotein (apo) C-II is a cofactor for lipoprotein lipase, the enzyme that catalyzes the hydirolysis of triglycerides on plasma triglyceride-rich lipoproteins. The complete coding sequence of apoC-II auRNA has been determined from an apoCJII clone isolated from a human liver cDNA library. A 17-base-long synthetic oligonucleotide based on amino acid residues 5-10 of apoC-II was utilized as a hybridization probe to select recombinant plasmids containing the apoC-II sequence. Two thousand four hundred clones were screened and one apoC-II cDNA clone containing 500 bases was identified. DNA sequence analysis of this cloie revealed a 101 amino acid C-II apolipoprotein containing a 22 amino acid signal peptide attached to the amino terminus of the 79 amino acid residue plasma apoC-II. The amino acid sequence of apoC-II determined by nucleic acid analysis is in agreement with the recently determined sequence of plasma apoC-II isolated from normal subjects. The'determination of the complete cDN4 sequence of apoC-II and the availability of a cDNA probe of apoC-Ii will facilitate oul analysis of the biosynthesis and processing as well as the genomic organization of apoC-II in normal subjects and patients with dyslipoproteinemias characterized by hypertriglyceridemia.
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Human plasma apolipoprotein (tpo) C-Il, a 79 amino acid protein, plays a pivotal role in lipid metabolism as a Mbfactor for lipoprotein lipase, the enzyme that hydrolyzes the triglycerides in plasma chylomicrohs and very low density lipoprot~ins (1) (2) (3) . apoC-II is synthesized primarily by the liver (4) and is present in human plasma at concentrations ranging from 2.2 to 5.5 mg/dl (5) . In plasma, apoC-II is reversibly bound principally by chylomicrons, very low density lipoproteins, and high density lipoproteins (6) . apoC-I in high density lipoproteins rapidly associates with newly secreted triglyceride-rich lipoproteins synthesized by the liver and intestine. Following lipolysis, triglyceride-rich lipoproteins are converted to remnants, and apoC-I4 dissociates from these particles and reassociates with high density lipoproteins (7) . The distribution of apoC-II on plasma lipoproteins is continually changing between high density lipoproteins and triglyceride-rich lipoproteins as a result of the secretion, metabolic conversion, and catabolism of the plasma lipoproteins (6) .
A deficiency of plasma apoC-II has been reported in patients with marked elevation of plasma triglycerides and chylomicrons, decreased low density and high density lipoproteins, and a type I hyperlipoproteinemia (8) (9) (10) (11) (12) (13) . Infusions of normal plasma (8, 11, 13) or isolated apoC-II fractions (14) result in a temporary reduction of plasma triglycerides and an increase in low density and high density lipoproteins. These findings substantiate the importance of apoC-II in triglyceride metabolism and in the modulation of the metabolic interconversion of triglyceride-rich lipoproteins.
The amino acid sequence of apoC-II from normal subjects and patients with type V hyperlipoproteinemia has been reported (15) . This sequence differs from that previously reported from other patients with type IV and type V hyperlipoproteinemias (16) . 1Recently, the partial sequence of preapoC-II has been published (17) . The existence of a preprotein in apoC-II would be anticipated since other apolipoproteins, including apolipoproteins A-I, A-II, A-IV, and C-III, have been reported to be synthesized as pre-or preproapolipoproteins (18) (19) (20) (21) (22) (23) .
To determine the-structure of the primary translated form of apoC-I and confirm the amino acid sequence of normal apoC-II we have cloned human apoC-II cDNA. In this report, we present the entire amino acid sequence of human liver preapoC-II as derived from its nucleic acid seqUence. METHODS Synthesis and Labeling of the Oligonucleotide Probe. A 17-base-long synthetic oligonucleotide mixture containing the coding sequence to amino acids residues 5-10 (Gln-Gln-AsPGlu-Met-Pro) of apoC-I1 (15) was obtained from P-L Biochemicals and used as a probe for screening of cDNA recombinant plasmids. This oligonucleotide is a mixture of 32 sequences designed to cover all possible codons for the amino acid residues 5-10 and was synthesized by the phosphotriester method (24) . A radiolabeled hybridization probe with a specific activity of 5 x. 106 cpm/pmol was prepared by phosphorylating the 5' OH end group of the synthetic oligonucleotide with T4 polynucleotide kinase (P-L Biochemicals) and [yy-32P]ATP (New England Nuclear, 3000
Ci/mmol; 1 Ci -37 GBq) as reported (19, 25) . The labeled oligonucleotide was separated from the reaction mixture by fractionation on a Sephadex G-50 superfine column (0.7 x 20 cm) equilibrated with 10 mM ammonium bicarbonate (pH 8.0). The fractions containing the oligonucleotide were pooled, Iyophilized once in the Speed-Vac (Savant), resuspended in 10 mM Tris-HCl/1 mM EDTA, pH 7.4, and utilized for screening of the cDNA library.
Screening of the Adult Normal Human Liver DoubleStranded cDNA Library. The double-stranded cDNA library used in these studies has been described elsewhere (18, 19) . Bacterial colonies that were to be screened for apoC-Il CDNA inserts were grown on tetracycline (12 ag/ml) plates for 12 hr at 370C and amplified in chloramphenicol (200 ,ug/ml) plates for 12 hr at 370C (26) . The colonies were then transferred to nitrocellulose membrane filter paper (0.45-1AM pore diameter), lyzed, neutralized, and baked (27) (28) (29) (30) . Filters were then prehybridized for 16 hr at 450C in 6 x NaCl/Cit (1 Proc. Nati. Acad. Sci. USA 81 (1984) vinylpyrrolidone)/0.5% NaDodSO4/1% dextran sulfate. Hybridization was performed for 16-20 hr at 450C in 6 x NaCl/Cit/5 x Denhardt's solution/0.5% NaDodSO4/10% dextran sulfate containing the 5'-end-labeled synthetic oligonucleotide (5-10 x 106 cpm per filter paper). Washings were performed in succession for 5 min each at room temperature, 37°C, 45°C, and 52°C with 2 x NaCl/Cit buffer. Filters were blotted dry and autoradiographed for hr.
Plasmid DNA Restriction Analysis. Bacterial cultures were grown in Luria broth supplemented with tetracycline at 10 ,ug/ml. Plasmid DNA was isolated by using the CsCl density gradient method as described (31 (19, 26) . Overlapping fragments were isolated by preparative gel electrophoresis on a 5% polyacrylamide gel at 140 V for 11/2 hr in TBE buffer. Nucleic acid sequence analysis was performed by the method of Maxam and Gilbert (32) .
RESULTS
Identification of apoC-II cDNA Clone. The human liver cDNA library was screened with a 17-base synthetic oligonucleotide containing the coding sequence for amino acid residues 5-10 of apoC-II. Two thousand four hundred clones were transferred to nitrocellulose filters and hybridized with this oligonucleotide probe. At a hybridization temperature of 45°C, one clone was identified with a positive hybridization signal that was maintained after washing at room temperature, 37°C, 45°C, and 52°C. This clone, which contained a 500-base-pair insert, was further analyzed by restriction endonuclease mapping.
Restriction Endonuclease Map of apoC-II. A restriction endonuclease cleavage map of the apoC-II clone is illustrated in Fig. 1 . Based on this map, restriction endonuclease cleavage sites were selected to obtain DNA fragments for use in establishing the nucleotide sequence of apoC-II. Six fragments were used to establish the sequence of the cloned cDNA of apoC-II: nucleotides -72 to + 57 were determined from the Pst I fragments, nucleotides + 10 to + 250 from the Ava II fragments, and nucleotides + 210 to + 400 from the Alu I fragment. Overlapping fragments were obtained by digestion with Bbv I (Fig. 1) .
Sequence Analysis of apoC-II Clone. Sequence analysis of radiolabeled overlapping fragments obtained from the restriction endonuclease digests revealed that the apoC-II clone encoded the entire sequence of 101 amino acid preapoC-II as well as a portion of the 3'-untranslated region of the mRNA. PreapoC-II contained a signal peptide of 22 residues attached to the amino-terminal end of plasma apoC-II (Fig. 2) . The complete nucleotide sequence and the derived amino acid sequence of human liver preapoC-II mRNA are illustrated in Fig. 3 .
DISCUSSION
In this report, we describe the amino acid sequence of human apoC-II as elucidated by nucleic acid sequence analysis of the cloned apoC-II cDNA. Our results are in agreement with our laboratory's recently reported amino acid sequence of plasma apoC-II isolated from normal and type V hyperlipidemic subjects (15 acid, respectively. These findings differ from the previously reported 78 amino acid apoC-II amino acid sequence from type IV and V hyperlipoproteinemic patients (16) . The reason for the variability in the sequence of apoC-II from hyperlipidemic patients is not yet known.
Several apolipoproteins (A-I, A-II, A-IV, and C-Ill) are now known to be synthesized as precursor proteins and undergo subsequent cotranslational or post-translational modifications (or both) (18) (19) (20) (21) (22) (23) . The apoC-II cDNA clone we have isolated codes for an additional 22 residues at the amino-terminal end of plasma apoC-II with a methionine at position -22. Analysis of this sequence reveals the presence of all three domains proposed for prepeptides (33) : an aminoterminal positively charged region with an arginine at position -19, a central core of hydrophobic residues extending from the leucine at position -14 to the leucine at position 7 , and a carboxyl-terminal glycine at the peptidase cleavage site. Glycine is one of five amino acids commonly encountered at the cleavage site (34) . These observations are consistent with the initial 22 residues of preapoC-IT being the signal peptide. Previous studies (22) have shown strong homology between the signal peptide region of human apoA-I and rat apoA-I and apoA-IV. We, however, do not find significant homology between the amino acid sequence of the signal peptide of apoC-IT and the other known preapolipoproteins.
A comparison of the amino acid sequence of plasma apoC-II and proapoA-I reveals that amino acid residues 5-8 and 10 (Gln-Gln-Asp-Glu-X-Pro) of plasma apoC-I are identical to residues -2 to + 2 and + 4 (Gln-Gln-Asp-Glu-X-Pro) of proapoA-I (19) . The Gln-Asp bond in proapoA-I is the site of extracellular proteolytic post-translational processing of proapoA-I to mature apoA-I. The conversion of proapoA-I to mature apoA-I has been analyzed in vitro (35, 36) and in vivo in man (37, 38) . The site of cleavage in proapoA-I is unusual since the majority of propeptides are cleaved intracellularly by a specific trypsin-like protease that recognizes a pair of basic amino acids at the cleavage site (34, 39, 40) . The similarity of the amino acid sequence of apoC-II and proapoA-I raises the possibility that amino acid residues [1] [2] [3] [4] [5] [6] of plasma apoC-I represent proapoC-IT and the protein isolated as "mature" apoC-II from plasma is in fact proapo-C-II. If this were the case it would represent a departure from the usual processing of proapolipoproteins since the predominant form in plasma is the mature form.
Recently we have definitively established the chromosomal location of apoC-II by filter hybridization analysis of human-mouse hybrid cells (41 We thank Glenn Gray for his technical advice.
